Search Within

Isabelle C Riviere

Formats
  1. Meeting Abstract (139)
  2. Journal Article (93)
  3. Book Section (2)
  4. Conference Paper (2)
  5. Review (2)
  6. Editorial (1)
  7. Research Letter (1)
Groups
  1. Department of Medicine (240)
  2. Hematologic Malignancies, Division of (240)
  3. GSK Faculty (219)
  4. Center for Hematologic Malignancies (216)
  5. Hematologic Malignancies Research (213)
  6. Sloan Kettering Institute Faculty (207)

More Groups

People
  1. Michel Sadelain (200)
  2. Xiuyan Wang (112)
  3. Renier Brentjens (111)
  4. Jae Park (83)
  5. Brigitte Senechal (42)
  6. Kevin Curran (40)

More People

Years
  1. 2025 (2)
  2. 2023 (11)
  3. 2022 (13)
  4. 2021 (13)
  5. 2020 (8)
  6. 2019 (18)

More Years

Publications
  1. Blood (55)
  2. Molecular Therapy (42)
  3. Journal of Clinical Oncology (20)
  4. Human Gene Therapy (10)
  5. Cancer Research (8)
  6. Haematologica (6)

More Publications

Publishers
  1. Nature Publishing Group (67)
  2. American Society of Hematology (56)
  3. American Society of Clinical Oncology (21)
  4. American Association for Cancer Research (15)
  5. Elsevier Inc. (15)
  6. Mary Ann Liebert, Inc (10)

More Publishers

Results (240)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL
    Journal Article

    Geyer, M. B.; Riviere, I.; Senechal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Palomba, M. L.; Halton, E.; more...
    JCI Insight (2019)

    Fulltext@MSK | Save
  • Establishing cGMP manufacturing of CRISPR/Cas9-edited human CAR T cells
    Meeting Abstract

    Zabierowski, S.; Eyquem, J.; Mansilla-Soto, J.; Feucht, J.; Wang, X.; Riviere, I.; Sadelain, M.
    Molecular Therapy (2019)

    Fulltext@MSK | Save
  • CAR-T cell manufacturing with CliniMACS Prodigy
    Meeting Abstract

    Wang, X.; Stefanski, J.; Chaudhari, J.; Hall, M.; Thummar, K.; Zhao, Z.; Sadelain, M.; Riviere, I.
    Molecular Therapy (2019)

    Fulltext@MSK | Save
  • GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
    Journal Article

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T. J.; Ng, K. Y.; Ghoddusi, M.; Purdon, T. J.; Wang, X.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save
  • CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
    Journal Article

    Hamieh, M.; Dobrin, A.; Cabriolu, A.; van der Stegen, S. J. C.; Giavridis, T.; Mansilla-Soto, J.; Eyquem, J.; Zhao, Z.; Whitlock, B. M.; Miele, M. M.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Generation of off-the-shelf TCR-less CAR-targeted cytotoxic T cells from renewable pluripotent cells for cancer immunotherapy
    Meeting Abstract

    Clarke, R. L.; van der Stegen, S.; Lee, T.; Mansilla-Soto, J.; Chang, C. W.; Sasaki, J.; Husain, M.; Peralta, E.; Hardy, I.; Ortiz, E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • CAR T cell therapy targeting G protein-coupled receptor class C group 5 member D (GPRC5D), a novel target for the immunotherapy of multiple myeloma
    Meeting Abstract

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T.; Ghoddusi, M.; Purdon, T. J.; Do, T.; Wang, X.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A phase I first-in-human clinical trial of CD19-targeted 19-28z/4-1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter's transformation
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Batlevi, C. L.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R. R.; Bernal, Y.; Hall, M.; Pineda, J.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity
    Meeting Abstract

    Smith, M.; Littmann, E. R.; Slingerland, J. B.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Schluter, J.; Park, J. H.; O'Cearbhaill, R.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save